Chemical Properties:
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement. Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moistureRuifu Chemical Supply Febuxostat Related Intermediates: Febuxostat CAS 144060-53-7 Ethyl 2-Chloroacetoacetate CAS 609-15-4 4-Hydroxythiobenzamide CAS 25984-63-8 Ethyl 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3 Ethyl 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7 Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-01-2 Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-03-4 Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161797-99-5| Item | Specifications |
| Appearance | Yellow to Light Yellow Powder |
| Solubility | 1.0g sample can be dissolved in 30ml dichloromethane and dimethyl sulfoxide |
| UV Identification | Maximum absorption at 260nm±3nm and 321nm±3nm wavelengths |
| Moisture (K.F) | ≤0.50% |
| Residue on Ignition | ≤0.50% |
| Unknown Single Impurity | ≤0.50% |
| Total Impurities | ≤1.0% |
| Purity / Analysis Method | ≥99.0% (Calculated on the anhydrous basis) |
| Test Standard | Enterprise Standard |
| Usage | Intermediate of Febuxostat (CAS: 144060-53-7) |
Description:
Specifications:
Package & Storage:
| Chemical Name | Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate |
| Synonyms | 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylic Acid Ethyl Ester; Febuxostat Intermediate |
| CAS Number | 161798-01-2 |
| CAT Number | RF-PI1111 |
| Stock Status | In Stock, Production Scale Up to Tons |
| Molecular Formula | C14H13NO4S |
| Molecular Weight | 291.32 |
| Melting Point | 113.0 to 117.0℃ |
| Brand | Ruifu Chemical |
Advantages:
FAQ:
Application:
Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate (CAS: 161798-01-2) is an intermediate of Febuxostat (CAS: 144060-53-7). Febuxostat is a new generation xanthine oxidase inhibitor developed by Tejin Co. (Japan,) used clinically for for long-term treatment of hyperuicemia (gout,) a new and highly effective non-purine selective inhibitor of xanthine oxidase. It is not recommended for gout patients without hyperuricemia.
